CL COLGATE PALMOLIVE CO
Perfumes, Cosmetics & Other Toilet Preparations · NYSE · SEC CIK 21665 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.9%
TTM net income YoY-29.4%
TTM EPS YoY-28.0%
Revenue 3-yr CAGR3.6%
Net income 3-yr CAGR9.0%
Margins
Gross margin60.6%
Operating margin14.8%
Net margin9.6%
FCF margin17.8%
EBITDA margin17.9%
Returns
ROE358.9%
ROA12.0%
ROIC (approx.)36.1%
Asset turnover1.24x
Leverage & solvency
Liabilities / assets96.2%
Debt / equity24.94x
Current ratio0.96x
Interest coverage12.64x
Cash quality & payout
Operating cash flow / net income2.13x
Accruals ratio-13.5%
Payout ratio—
Capex / revenue2.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $5.37B | $5.36B | $5.32B | $5.23B | $5.13B | $5.11B | $4.91B | $4.95B |
| Cost of revenue | $2.14B | $2.06B | $2.10B | $2.08B | $2.08B | $2.04B | $1.92B | $1.96B |
| Gross profit | $3.23B | $3.30B | $3.23B | $3.15B | $3.05B | $3.07B | $2.99B | $2.98B |
| SG&A expense | $2.11B | $2.13B | $2.08B | $2.07B | $1.97B | $1.96B | $1.90B | $1.90B |
| Operating income | $1.09B | $1.02B | $964.00M | $92.00M | $1.06B | $1.08B | $1.08B | $1.06B |
| Interest expense | $62.00M | $62.00M | $62.00M | $64.00M | $67.00M | $71.00M | $66.00M | $66.00M |
| Pretax income | $1.02B | $950.00M | $892.00M | $108.00M | $992.00M | $1.01B | $953.00M | $993.00M |
| Income tax | $240.00M | $231.00M | $211.00M | $113.00M | $226.00M | $234.00M | $227.00M | $214.00M |
| Net income | $751.00M | $693.00M | $646.00M | -$37.00M | $735.00M | $743.00M | $690.00M | $739.00M |
| EBITDA | $1.25B | $1.17B | $1.12B | $265.00M | $1.22B | $1.23B | $1.22B | $1.21B |
| EPS (basic) | 0.94 | 0.87 | 0.81 | — | 0.91 | 0.92 | 0.85 | — |
| EPS (diluted) | 0.94 | 0.86 | 0.80 | — | 0.91 | 0.91 | 0.85 | — |
| Dividends declared per share | 0.53 | 0.53 | 0.53 | 0.52 | 0.52 | 0.52 | 0.52 | 0.50 |
| Weighted avg. shares (diluted) | 799.70M | 801.80M | 805.10M | — | 810.20M | 813.30M | 815.00M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $1.53B | $1.37B | $1.33B | $1.29B | $1.28B | $1.22B | $1.11B | $1.10B |
| Short-term investments | — | — | — | $107.00M | — | — | — | $160.00M |
| Receivables | $1.90B | $1.96B | $1.89B | $1.68B | $1.81B | $1.77B | $1.73B | $1.52B |
| Inventory | $2.18B | $2.18B | $2.09B | $2.03B | $2.11B | $2.12B | $2.12B | $1.99B |
| Current assets | $6.36B | $6.31B | $6.08B | $5.71B | $6.04B | $6.00B | $5.81B | $5.32B |
| PP&E, net | $4.61B | $4.64B | $4.62B | $4.66B | $4.56B | $4.53B | $4.42B | $4.42B |
| Goodwill | $3.08B | $3.10B | $3.11B | $3.12B | $3.70B | $3.70B | $3.33B | $3.27B |
| Intangibles | $1.47B | $1.50B | $1.52B | $1.54B | $1.89B | $1.90B | $1.78B | $1.76B |
| Total assets | $16.74B | $16.79B | $16.61B | $16.33B | $17.51B | $17.47B | $16.65B | $16.05B |
| Current liabilities | $6.64B | $6.15B | $5.93B | $6.85B | $6.50B | $6.78B | $6.86B | $5.76B |
| Short-term debt | — | — | — | $1.11B | — | — | $1.70B | $652.00M |
| Long-term debt | $7.18B | $7.82B | $7.94B | $6.87B | $7.31B | $7.14B | $6.57B | $7.29B |
| Total debt | $7.18B | $7.82B | $7.94B | $7.99B | $7.31B | $7.14B | $8.27B | $7.94B |
| Total liabilities | $16.10B | $16.22B | $16.12B | $15.96B | $16.27B | $16.42B | $15.91B | $15.50B |
| Shareholders' equity | $288.00M | $236.00M | $145.00M | $54.00M | $856.00M | $702.00M | $363.00M | $212.00M |
| Net debt | $5.66B | $6.45B | $6.60B | $6.70B | $6.03B | $5.93B | $7.16B | $6.84B |
| Shares outstanding | — | — | — | 801.24M | — | — | — | 812.57M |
| Cash flow statement | ||||||||
| Operating cash flow | $1.17B | $995.00M | $747.00M | $1.45B | $1.26B | $884.00M | $600.00M | $1.27B |
| Capital expenditure | $134.00M | $128.00M | $138.00M | $177.00M | $155.00M | $108.00M | $124.00M | $184.00M |
| Free cash flow | $1.04B | $867.00M | $609.00M | $1.28B | $1.11B | $776.00M | $476.00M | $1.08B |
| Investing cash flow | -$137.00M | -$122.00M | -$122.00M | -$103.00M | -$154.00M | -$401.00M | -$159.00M | -$80.00M |
| Financing cash flow | -$858.00M | -$851.00M | -$563.00M | -$1.36B | -$1.03B | -$409.00M | -$458.00M | -$1.28B |
| Depreciation & amortization | $159.00M | $155.00M | $156.00M | $173.00M | $158.00M | $151.00M | $148.00M | $148.00M |
| Stock-based compensation | $63.00M | $38.00M | $40.00M | $28.00M | $72.00M | $32.00M | $23.00M | $27.00M |
| Share buybacks | $330.00M | $291.00M | $306.00M | $406.00M | $288.00M | $232.00M | $284.00M | $455.00M |
Free plan shows the latest 8 periods; Pro shows all 74 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.